This is a synthetic peptide designed for use in combination with anti-NAPSA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
NAPSA
(Napsin A Aspartic Peptidase (NAPSA))
Synonyme
KAP Peptide, Kdap Peptide, NAP1 Peptide, NAPA Peptide, SNAPA Peptide, pronapsin Peptide, kap Peptide, kdap Peptide, nap1 Peptide, napa Peptide, napsa Peptide, snapa Peptide, napsin A aspartic peptidase Peptide, napsin A aspartic peptidase L homeolog Peptide, NAPSA Peptide, Napsa Peptide, napsa.L Peptide
Hintergrund
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.